Late Friday, the Center for Medicare and Medicare Services released draft Medicare reimbursement rates for 2018 that were far worse than anyone expected. The word “draconian” has been used in several research notes.
Monday, September 25, 2017
Quest Diagnostics (DGX) : Medicare proposes reimbursement cuts
Shares of Quest Diagnostics and its biggest rival LabCorp are falling sharply today in reaction to proposed Medicare reimbursement cuts that have been described by some analysts as "draconian."
The market for medical testing services is dominated by two players, Quest Diagnostics (DGX) and LabCorp (LH). The two companies each run a large chain of laboratories that conduct a slew of medical tests that help doctors diagnose and treat patients.
Late Friday, the Center for Medicare and Medicare Services released draft Medicare reimbursement rates for 2018 that were far worse than anyone expected. The word “draconian” has been used in several research notes.
Late Friday, the Center for Medicare and Medicare Services released draft Medicare reimbursement rates for 2018 that were far worse than anyone expected. The word “draconian” has been used in several research notes.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment